ConductScience.org, home

Paper · 312265

Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response.

Rubin AS. Immunology, 1979. Cited by 10 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response. Papers, record 312265. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/312265

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response.
PubMed
Journal
Immunology
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rubin ASA S

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody FormationMajor topic
T-LymphocytesMajor topic
Animals
B-Lymphocytes
Cells, Cultured
Colony-Forming Units Assay
Female
Lymphocyte Cooperation
Mice
Mice, Inbred Strains
Spleen

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
175,231
Antigen-specific T-cell-mediated suppression. I. Induction of L-glutamic acid60-L-alanine30-L-tyrosine10 specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen.
J Exp Med1978https://conductscience.org/library/papers/75231PubMed
2338,477Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro.Immunology1977https://conductscience.org/library/papers/338477PubMed
3324,897Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells.Immunology1977https://conductscience.org/library/papers/324897PubMed
4302,181The role of the histocompatibilty gene complex in lymphocyte defferetiation.Cold Spring Harb Symp Quant Biol1977https://conductscience.org/library/papers/302181PubMed
5302,180The significance of T-B collaboration across haplotype barriers.Cold Spring Harb Symp Quant Biol1977https://conductscience.org/library/papers/302180PubMed
6303,152Dual biological function of a T-cell-derived murine immunoenhancing factor.Cell Immunol1977https://conductscience.org/library/papers/303152PubMed
71,086,318Differences in the age-dependent release of a low molecular weight suppressor (LMWS) and stimulators by normal and nzb/w lymphoid organs.J Immunol1976https://conductscience.org/library/papers/1086318PubMed
84,116,319The regulatory influence of activated T cells on B cell responses to antigen.Adv Immunol1972https://conductscience.org/library/papers/4116319PubMed
94,118,414Specific heterologous enhancement of immune responses. IV. Specific generation of a thymus-derived enhancing factor.J Exp Med1972https://conductscience.org/library/papers/4118414PubMed
104,126,290Reconstitution of T cell-depleted spleen cell populations by factors derived from T cells. 3. Mechanism of action of T cell-derived factors.J Immunol1973https://conductscience.org/library/papers/4126290PubMed

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
6,972,349Polyclonal immunoglobulin synthesis induced by a macrophage factor acting via T cells.Immunology1981https://conductscience.org/library/papers/6972349PubMed
6,682,089Relationship between a spleen-derived immunosuppressive peptide 'SDIP' and the 'Facteur thymique sérique' (FTS): biochemical and biological comparison of the two factors.Immunology1983https://conductscience.org/library/papers/6682089PubMed
6,168,568Participation of diffusible products in the in vivo immune primary response to red blood cells.Immunology1981https://conductscience.org/library/papers/6168568PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/312265

GET https://conductscience.org/api/papers/v1/312265/references?page=2